Harvard Bioscience, Inc. - Common Stock — Balance Sheet (NASDAQ:HBIO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 156.25 M162.34 M145.36 M137.37 M126.64 M80.07 M Total liabilities 79.57 M78.94 M73.14 M64.29 M63.3 M66.34 M Total equity 76.68 M83.4 M72.22 M73.07 M63.34 M13.73 M Total liabilities & shareholders' equities 156.25 M162.34 M145.36 M137.37 M126.64 M80.07 M Total debt 46.29 M45.09 M43.01 M30.7 M035.87 M Net debt 46.29 M45.09 M43.01 M30.7 M035.87 M

News

Benchmark raises Harvard Bioscience stock price target to $6 on reverse split

Benchmark cuts Harvard Bioscience stock price target on NIH concerns

Harvard Bioscience, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:HBIO) 2026-03-13

Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high

Harvard Bioscience earnings missed by $0.10, revenue topped estimates

Harvard Bioscience executes 1-for-10 reverse stock split

Harvard Bioscience reports Q4 revenue in line with guidance

What's Going On With Harvard Bioscience Stock Friday? - Harvard Bioscience (NASDAQ:HBIO)

Harvard Bioscience to close Holliston plant in manufacturing consolidation

Harvard Bioscience secures $40 million credit facility from BroadOak

Harvard Bioscience, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:HBIO) 2025-11-07

Harvard Bioscience Q3 2025 slides: EPS miss overshadows operational improvements